Evidence map›Paper›PMID 33931817›Full record

ArticleApplied biochemistry and biotechnology2021

Buried Kex2 Sites in Glargine Precursor Aggregates Prevent Its Intracellular Processing in Pichia pastoris Mut

Abel Caballero-Pérez, José María Viader-Salvadó, Ana Lucía Herrera-Estala, José Antonio Fuentes-Garibay, Martha Guerrero-Olazarán

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Effect ofPeerJ · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abel Caballero-PérezInstituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, UANL, 66455, San Nicolás de los Garza, N.L, Mexico.
José María Viader-SalvadóInstituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, UANL, 66455, San Nicolás de los Garza, N.L, Mexico.
Ana Lucía Herrera-EstalaInstituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, UANL, 66455, San Nicolás de los Garza, N.L, Mexico.
José Antonio Fuentes-GaribayInstituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, UANL, 66455, San Nicolás de los Garza, N.L, Mexico.
Martha Guerrero-OlazaránInstituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, UANL, 66455, San Nicolás de los Garza, N.L, Mexico. martha.guerrerool@uanl.edu.mx.ORCID http://orcid.org/0000-0002-4253-0881
Universidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glargine is a long-acting insulin analog with less hypoglycemia risk. Like human insulin, glargine is a globular protein composed of two polypeptide chains linked by two disulfide bonds. Pichia pastoris KM71 Mut

Indexed as

Hot TemperatureProtein AggregatesHumansInsulin GlargineMethanolProtein PrecursorsProtein Processing, Post-TranslationalRecombinant ProteinsSaccharomycetalesInsulin GlargineMethanolProtein AggregatesProtein PrecursorsRecombinant ProteinsKex2 proteaseMethanol limited fed-batch cultureMethanol non-limited fed-batch cultureMuts phenotypePichia pastorisSingle-chain insulin glargine

Identifiers

PMID33931817
OpenAlexW3159504065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.